MEA Oxygen Therapy Market

MEA Oxygen Therapy Market Size (2023 to 2028)

The Oxygen Therapy Market size in the Middle East and Africa was worth USD 0.194 billion in 2022 and is estimated to be growing at a CAGR of 2.204% to reach USD 0.216 billion by 2028.

An increase in tobacco consumption and the prevalence of respiratory illnesses, a preference for standalone oxygen therapy devices over portable oxygen therapy devices, and constant technological improvements in the field of oxygen therapy are primarily driving the growth of the oxygen therapy market in the Middle East and Africa.

Oxygen therapy is often utilized to treat various respiratory illnesses due to its beneficial palliative and supplementary role. Furthermore, the development of efficient and advanced technology and a rapidly aging population at risk of developing respiratory diseases are further predicted to favor the oxygen therapy market in the MEA region to register a steady growth during the forecast period.

The rise in the usage of standalone oxygen therapy devices has been attributed to an increase in cigarette smoking, the prevalence of respiratory disorders, and a preference for freestanding oxygen therapy devices over inhalers. Furthermore, continuous technological advancements in oxygen therapy and portable oxygen therapy equipment are also expected to accelerate the adoption of oxygen therapy in this region. In addition, the increased number of people suffering from respiratory diseases is expected to drive market expansion.

However, strict regulatory rules may cause delays in the clearance of oxygen therapy equipment, limiting the market's growth. The expansion of the market is further anticipated to be stymied by the availability of low-cost competitors from local manufacturers, strict regulatory standards that cause delays in product approvals, and Medicare reimbursement rate cuts for home oxygen treatment in the United Arab Emirates. The market growth in the Middle East and Africa is also projected to be suffocated by a cumbersome regulatory environment. The absence of developed infrastructure in emerging nations that would allow for at-home treatment is another aspect that is predicted to pose a challenge to the MEA market.

This research report on the Middle East and Africa oxygen therapy market has been segmented & sub-segmented into the following categories:

By Product Type:

• Oxygen Source Equipment
  • Oxygen Concentrators   
    • Fixed Oxygen Concentrators
    • Portable Oxygen Concentrators
  • Liquid Oxygen Devices   
  • Oxygen Cylinders             
• Oxygen Delivery Devices                  
  • Oxygen Masks   
  • Nasal Cannulas  
  • Venturi Masks   
  • Non-Rebreather Masks 
  • Bag Valve Masks               
  • Other Devices    

By Application:

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia

By End-user:

• Home Healthcare
• Hospitals

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The oxygen therapy market in the Middle East and Africa is predicted to account for a moderate share in the global market during the forecast period. The growing need for at-home care among the elderly, the well-developed healthcare infrastructure that supports modern healthcare institutions, and the presence of significant players in the Middle East and Africa, such as Kuwait and the United Arab Emirates, all contribute to the region's supremacy.

The United Arab Emirates is expected to lead the MEA market due to increasing COPD cases among its residents. In addition, technical improvements, improved infrastructure, equipment, and a high level of knowledge about the availability of therapy for various chronic respiratory ailments are projected to drive the market during the forecast period.

KEY MARKET PLAYERS:

Companies like Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc. are playing an essential role in the MEA Oxygen Therapy Market.